Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adult-onset type II citrullinemia

Liver Transplantation

Volumn 10, Issue 4, 2004, Pages 550-554

  Yazaki, Masahide ^a   Hashikura, Yasuhiko ^a   Takei, Yo Ichi ^a   Ikegami, Toshihiko ^a   Miyagawa, Shin Ichi ^a   Yamamoto, Kanji ^a   Tokuda, Takahiko ^a   Kobayashi, Keiko ^b   Saheki, Takeyori ^b   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMMONIA; ARGINASE; ARGININE; ARGININOSUCCINATE LYASE; ARGININOSUCCINATE SYNTHASE; BENZOIC ACID; CARBAMATE KINASE; CITRULLINE; DNA; KANAMYCIN; LACTULOSE; ORNITHINE CARBAMOYLTRANSFERASE; PREALBUMIN; SERINE;

ADULT; ARTICLE; CADAVER DONOR; CASE REPORT; CITRULLINEMIA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DNA DETERMINATION; ELECTROENCEPHALOGRAPHY; ENZYME ANALYSIS; ENZYME DEFICIENCY; FAMILIAL AMYLOID POLYNEUROPATHY; FEASIBILITY STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; JAPAN; LABORATORY TEST; LIVER CELL; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MARRIAGE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PARENTERAL NUTRITION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN RESTRICTION; SAFETY; SURGICAL TECHNIQUE; SYMPTOM; TREATMENT OUTCOME;

ADULT; CITRULLINEMIA; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; TREATMENT OUTCOME;

EID: 11144354271     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20131     Document Type: Article

References (16)

1. Brusilow SW, Horwich AL. Urea cycle enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill Information Service Co., 1995:1187-1232.
2. Saheki T, Kobayashi K, Inoue I. Hereditary disorders of the urea cycle in man: Biochemical and molecular approach. Rev Physiol Biochem Pharmacol 1987;108:21-68.
3. Kobayashi K, Sinasac DS, Iijima M, Boright AP, Begum M, Lee JR, et al. The gene mutated in adult-onset type II citrullinemia encodes a putative mitochondrial carrier protein. Nat Genet 1999;22:159-163.
4. Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 2002;47:333-341.
5. Ikeda S, Takei Y, Hashikura Y. Liver transplantation as treatment for neurological disorders. Expert Rev Neurotherapeutics 2003;3:547-555.
6. Todo S, Starzl TE, Tzakis A, Benkov KJ, Kalousek F, Saheki T, et al. Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 1992;15:419-422.
7. Yazaki M, Ikeda S, Takei Y, Yanagisawa N, Matsunami H, Hashikura Y, et al. Complete neurological recovery of an adult patient with type II citrullinemia after living related partial liver transplantation. Transplantation 1996;62:1679-1681.
8. Ikeda S, Yazaki M, Takei Y, Ikegami T, Hashikura Y, Kawasaki S, et al. Type II (adult onset) citrullinemia: Clinical pictures and the therapeutic effect of liver transplantation. J Neurol Neurosurg Psychiatry 2001;71:663-670.
9. Imamura Y, Kobayashi K, Shibatou T, Aburada S, Tahara K, Kubozono O, Saheki T. Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: A case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res 2003;26:68-72.
10. Ikegami T, Kawasaki S, Ohno Y, Chisuwa H, Urata K, Nakazawa Y, et al. Temporary auxiliary liver transplantation from a living donor to an adult recipient with familial amyloid polyneuropathy. Transplantation 2002;73:628-630.
11. Furtado A, Tome L, Oliveira FJ, Furtado E, Viana J, Perdigoto R. Sequential liver transplantation. Transplant Proc 1997;29: 467-468.
12. Azoulay D, Samuel D, Castaing D, Adam R, Adams D, Said G, Bismuth H. Domino liver transplants for metabolic disorders: Experience with familial amyloidotic polyneuropathy. J Am Coll Surg 1999;189:584-593.
13. Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li YF, et al. Usefulness of MALDI/TOF mass spectrometry immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid 1999;6:282-288.
14. Gubernatis G, Pichlmayr R, Kemnitz J, Gratz K. Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: First successful case report. World J Surg 1991; 15:660-665.
15. Kasahara M, Kiuchi T, Uryuhara K, Ogura Y, Takakura K, Egawa H, et al. Treatment of ornithine transcarbamylase deficiency in girls by auxiliary liver transplantation: Conceptual changes in a living-donor program. J Pediatr Surg 1998;33: 1753-1756.
16. Kobayashi K, Iijima M, Yasuda T, Sinasac DS, Yamaguchi M, Tsiu LC, et al. Type II citrullinemia (citrin deficiency): A mysterious disease caused by a defect of calcium-binding mitochondrial carrier protein. In: Pochet R, Donato R, Haiech J, Heizmann C, Gerke V, eds. Calcium: The molecular basis of calcium action in biology and medicine. Netherlands: Kluwer Academic Publishers, 2000:565-587.